← All peptidesBlends
CJC-1295 (no DAC) + Ipamorelin
CJC-1295 (no DAC) + Ipamorelin
Most popular GH-secretagogue pairing, studied for amplifying pulsatile GH release with minimal cortisol/prolactin impact.
Typical dose
100–300 mcg
Frequency
1-3x daily (often pre-bed)
Half-life
0.5 h
Route
subcutaneous
Typical vial sizes
10 mg20 mg
Sample reconstitution
10 mg vial · 2 mL bac water · 200 mcg dose
- Draw volume
- 0.040 mL
- Insulin units
- 4 units
- Concentration
- 5.00 mg/mL
- Doses per vial
- 50.0
Research notes
As sold: CJC-1295 no-DAC 5mg + Ipamorelin 5mg (1:1). ~100-300mcg of each to match short half-lives.
Further reading
- Published research on CJC-1295 (no DAC) + Ipamorelin (PubMed) →
- Clinical trials for CJC-1295 (no DAC) + Ipamorelin (ClinicalTrials.gov) →
Links open live searches on authoritative databases — verify dosing and safety against primary sources.
Research use only.
Information on this page is a reference log compiled from public sources and is not medical advice. Consult a licensed physician before making any decisions about your health.